Zdrowie i gospodarka · 27/12/2018

FDA Debars Dr. Ranjan Bhandari for 3 Years Over Misdemeanor Conviction

The FDA has issued a 3-year debarment order against Dr. Ranjan Bhandari, MD, for a misdemeanor conviction under the FD&C Act, which involved misbranding prescription drugs. The FDA determined that Dr. Bhandari's conduct undermines the regulation of drugs and that his failure to request a hearing constitutes a waiver of his right to a hearing.